Vigor Medical Technologies

Company Overview

Snapshot

Founded in July 2014 by Irina Kavounovski, John H Abeles MD, and Igor Weisbein, Vigor Medical Technologies operates with 1–10 employees. The company has raised $3.9M across four funding rounds.

Business overview

Vigor Medical Technologies develops life-saving medical devices for treating chest trauma and facilitating thoracic/abdominal drainage. Its core product, the C-Lant self-fixation sealing device, is designed to prevent lung and heart collapse. The company serves emergency medical services, first aid organizations, and hospital departments including ER, trauma, thoracic/abdominal surgery, and pulmonary, operating within the Health Tech & Life Sciences sector.

Strategic signal

In November 2025, Vigor Medical Technologies was featured for its work in transforming ultrasound into a smart, AI-based tool for the battlefield. This highlights the company's strategic pivot towards integrating advanced technologies like AI into its medical devices, signaling a commitment to innovation and expanding its market reach beyond traditional emergency care to military applications, which could attract significant defense and healthcare investment.

Company Intelligence Q&A

What is Vigor Medical Technologies' primary focus?

Vigor Medical Technologies specializes in developing life-saving devices for treating chest trauma and thoracic/abdominal drainage, with a flagship product designed to prevent lung and heart collapse.

When was Vigor Medical Technologies founded?

Vigor Medical Technologies was founded in July 2014.

What is the C-Lant device?

The C-Lant is Vigor Medical Technologies' self-fixation sealing device, designed to prevent lung and heart collapse in patients suffering from chest trauma.